| Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection | 2007/06/01 | English | 372 |
| Diabetic cardiomyopathy: pathophysiology and clinical features | 2012/03/28 | English | 312 |
| Return to the fetal gene program protects the stressed heart: a strong hypothesis | 2007/05/22 | English | 293 |
| The mechanisms of air pollution and particulate matter in cardiovascular diseases | 2017/03/16 | English | 282 |
| Fibrosis and heart failure | 2012/11/04 | English | 241 |
| Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment | 2011/05/28 | English | 239 |
| Signaling pathways in ischemic preconditioning | 2007/05/22 | English | 219 |
| Strain imaging using cardiac magnetic resonance | 2017/06/15 | English | 218 |
| Systemic inflammation in heart failure – The whys and wherefores | 2006/03/01 | English | 205 |
| The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure: an evidence-based review | 2007/11/07 | English | 200 |
| The fibrosis-cell death axis in heart failure | 2016/02/16 | English | 183 |
| Clinical Characteristics, Demographics and Prognosis of Transient Left Ventricular Apical Ballooning Syndrome | 2005/12/01 | English | 181 |
| Role of cytokines and inflammation in heart function during health and disease | 2018/06/04 | English | 172 |
| Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities | 2010/07/10 | English | 165 |
| Symptom burden in heart failure: assessment, impact on outcomes, and management | 2016/09/03 | English | 165 |
| TNFα in myocardial ischemia/reperfusion, remodeling and heart failure | 2010/06/23 | English | 163 |
| Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs | 2014/11/19 | English | 161 |
| Chronic kidney disease and cardiovascular complications | 2014/10/25 | English | 161 |
| Mitochondrial dysfunction in heart failure | 2012/09/05 | English | 159 |
| Age-associated changes in cardiovascular structure and function: a fertile milieu for future disease | 2011/08/02 | English | 154 |
| β-Adrenergic stimulation and myocardial function in the failing heart | 2008/12/27 | English | 150 |
| Depression and anxiety as predictors of mortality among heart failure patients: systematic review and meta-analysis | 2015/11/16 | English | 149 |
| Proinflammatory cytokines in heart failure: double-edged swords | 2010/04/20 | English | 147 |
| Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome | 2011/06/19 | English | 147 |
| Mineralocorticoid Receptors: Distribution and Activation | 2005/01/01 | English | 146 |
| Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes | 2015/11/05 | English | 143 |
| Biomarkers of inflammation in heart failure | 2009/04/12 | English | 141 |
| Epicardial adipose tissue as a metabolic transducer: role in heart failure and coronary artery disease | 2017/07/31 | English | 140 |
| BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review | 2014/07/26 | English | 139 |
| Advanced glycation end products: role in pathology of diabetic cardiomyopathy | 2013/02/13 | English | 132 |